App Intel

eCura system

Live東北大学病院消化器内科・大腸グループ4 apps · 2.2K installsMedicalFreehatta.eCura

A scoring system to stratify curability after ESD for early gastric cancer.

Alert me★ WatchOpen in Play ↗
Total installs
1,284
exact · Play shows 1,000+
Installs / day
0
since last crawl
Rating
—★
— ratings · — reviews
Released
6 Dec 2019
6.9y ago
Last update
13 Aug 2025
v1.5 · 1.2y ago
Countries
—
not checked yet

Install history

exact counter from Google Play
1.3K1.4K1.6K1.8K2K11 Oct12 Oct12 Oct
1.3K1.4K1.6K1.8K2K11 Oct12 Oct12 Oct

Installs per day · last 90 days

Not enough history yet — check back tomorrow

Change timeline

No changes recorded yet. We compare every crawl with the previous one and list title, icon, screenshots, description, version, price and availability changes here.

Country availability

Availability has not been checked for this app yet. “Check all countries” looks the app up in about 140 Google Play storefronts and shows where it is live, listed but not installable, or missing — plus any country-specific (custom) store listings.

Top countries

Country data will be available soon.

We estimate where downloads come from using the app’s position in Google Play’s top charts in about 140 countries. This app is not in any chart we have collected yet; the estimate appears as soon as it is.

Top chart positions

Not in any tracked top chart.

App manifest

Read this app's manifest from Google Play: permissions, declared SDKs, components and AdMob app ID. Saved analysis appears here automatically.

Manifest analysis reads only the required APK ranges. Base APK downloads may need separate device splits to install.

Data safety

declared by the developer on Google Play
  • No data shared with third parties
  • No data collected

This is the developer's own declaration, summarised from the Play listing. The permissions below show what the app is technically able to access.

Permissions

1 in 1 group
0 Sensitive0 Notable1 Routine
OtherRoutine1

Access to miscellaneous device features that don't fit other categories

  • Check with Google Play that you got this app legitimatelyGoogle Play license check · com.android.vending.CHECK_LICENSE

Sensitive = can reach personal data, location, camera/mic or act on your behalf. Notable = changes how your device behaves. Routine = normal for almost every app. Source: Google Play's permission list for all versions of this app.

Store listing

Full description
Lymph node metastasis (LNM) was found in only 5–10% of patients with early gastric cancer. The "eCura system" is a scoring system to stratify curability after ESD for early gastric cancer. Five risk factors for LNM were weighted with point values: three points for lymphatic invasion and 1 point each for tumor size >30 mm, positive vertical margin, venous invasion, and submucosal invasion ≥500μm. The patients were categorized into three LNM risk groups: low (0–1 point: 2.5% risk), intermediate (2–4 points: 6.7%), and high (5–7 points: 22.7%). For more information, see the reference below. Am J Gastroenterol. 2017 Jun;112(6):874-881. A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: "eCura system". Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y, Hoteya S, Nakagawa M, Hirano M, Esaki M, Matsuda M, Ohnita K, Yamanouchi K, Yoshida M, Dohi O, Takada J, Tanaka K, Yamada S, Tsuji T, Ito H, Hayashi Y, Nakaya N, Nakamura T, Shimosegawa T. You can view the application help by tapping a title bar. DISCLAIMER: This application is intended for educational purposes only. It will help you understand the above paper. It does not create any patient-physician relationship, and should not be used as a substitute for professional diagnosis and treatment. [Developer] 2020 東北大学病院消化器内科・大腸グループ http://www.gastroente.med.tohoku.ac.jp/ [email protected] Kenichi Negoro, MD, PhD (Android) Yoichi Kakuta, MD, PhD (iOS) Waku Hatta, MD, PhD (Adviser) Xiaoyi Jin, MD, PhD (Translation)

What's new

Added support for Android 16 (API level 36).

Growing in Medical

Category →